Compounds 3a [1-(3′,4′-methylenedioxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline] and 3b [1-(6′-bromo-3′,4′-dimethoxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline] demonstrated dose-dependent (5-75 μM) negative inotropic effects. Compound 5 [1,3-bis-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin- 1-yl)propane] demonstrated a two-phase inotropic effect. The experimental results and a literature analysis suggested that the negative inotropic effects of the tested compounds (3a, 3b, 5) could be due to their influences on the [Ca2+]i concentration through blocking of cardiomyocyte Na+- and Ca2+-channels. The positive inotropic effect of free base 5 could be related to modulation of cardiomyocyte muscarinic receptor activity.
Similar content being viewed by others
References
M. D. Mashkovskii, Drugs [in Russian], Vol. 1, Ibn Sino, Tashkent (1998).
Yu. V. Shklyaev, B. Ya. Syropyatov, and V. S. Shklyaev, Bashk. Khim. Zh., 4(4), 19 – 33 (1997).
G. Bringmann, Bull. Soc. Chim. Belg., 105(10 – 11), 601 (1996).
V. A. Glushkov, Doctoral Dissertation, Perm (2006), pp. 7 – 35.
J.-J. Lu, J.-L. Bao, X.-P. Chen, et al., Evidence-Based Complementary Altern. Med., 1 – 12 (2012).
Y. Kashiwada, A. Aoshima, Y. Ikeshiro, et al., Bioorg. Med. Chem., 13(2), 443 – 448 (2005).
Y. Kotake, Y. Tasaki, Y. Makino, et al., J. Neurochem., 65(6), 2633 – 2638 (1995).
N. Cabedo, P. Protais, B. K. Cassels, et al., J. Nat. Prod., 61, 709 – 712 (1998).
M. L. Candenas, E. Naline, M. P. D’Ocon, et al., J. Pharm. Pharmacol., 42(2), 102 – 107 (1990).
K. Zaima, Y. Takeyama, I. Koga, et al., J. Nat. Med., 66(3), 421 – 427 (2012).
L. L. Gong, L. H. Fang, S. B. Wang, et al., Atherosclerosis, 222(1), 50 – 58 (2012).
G. H. Whipple, Angiology, 28(11), 737 – 749 (1977).
J. Q. Qian, Acta Pharmacol. Sin., 23, No. 12, 1086 – 1092 (2002).
B. Ya. Syropyatov, Yu. V. Shklyaev, V. S. Shklyaev, et al., Khim.-farm. Zh., 33(9), 8 – 10 (1999).
J. L. Neumeyer, C. Perianayagam, and S. Ruchirawat, J. Med. Chem., 20(7), 894 – 898 (1977).
Sh. N. Zhurakulov, V. I. Vinogradova, and M. G. Levkovich, Khim. Prir. Soedin., No. 1, 62 – 68 (2013).
A. Sh. Saidov, E. Yu. Mazur, K. K. Turgunov, et al., Khim. Prir. Soedin., No. 3, 435 (2014).
Lin Ping Fa, Master’s Thesis, China (2010).
S. Z. Xu, Y. Zhang, J. Y. Ren, et al., Zhongguo Yaoli Xuebao, 18(6), 515 – 518 (1997).
J. A. Martinez, A. Bello, L. L. Rubio, et al., Fundam. Clin. Pharmacol., 12(2), 182 – 187 (1998).
M. J. Su, P. J. Liu, C. D. Tseng, et al., J. Formosan Med. Assoc., 93(8), 673 – 680 (1994).
U. Borchard, A. A. Fox, and K. Greeff, Naunyn-Schmiedeberg’s Arch. Pharmacol., 312(2), 187 – 192 (1980).
R. D. Harvey and A. E. Belevych, Br. J. Pharmacol., 139, 1074 – 1084 (2003).
R. I. Hussain, E. Qvigstad, J. A. Birkel, et al., Br. J. Pharmacol., 156(4), 575 – 586 (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 54, No. 1, pp. 9 – 13, January, 2020.
Rights and permissions
About this article
Cite this article
Khushmatov, S.S., Zhumaev, I.Z., Zhurakulov, S.N. et al. Synthesis and Comparative Inotropic Effects of Several Isoquinoline Alkaloids. Pharm Chem J 54, 7–11 (2020). https://doi.org/10.1007/s11094-020-02148-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-020-02148-4